Remove trial restrictions ▶ Start for $1

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Merck
Mallinckrodt
Dow
Johnson and Johnson
Baxter

Last Updated: September 26, 2022

Nortriptyline hydrochloride - Generic Drug Details


✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $1
Remove trial restrictions


What are the generic sources for nortriptyline hydrochloride and what is the scope of freedom to operate?

Nortriptyline hydrochloride is the generic ingredient in four branded drugs marketed by Lilly, Ani Pharms, Aurobindo Pharma Ltd, Mayne Pharma, Mylan, Taro, Teva, Zydus, Specgx Llc, Ranbaxy, and Pharm Assoc, and is included in fourteen NDAs. Additional information is available in the individual branded drug profile pages.

There are five drug master file entries for nortriptyline hydrochloride. Twenty-six suppliers are listed for this compound.

Summary for nortriptyline hydrochloride
Recent Clinical Trials for nortriptyline hydrochloride

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Chang Gung Memorial HospitalPhase 2
Assiut UniversityN/A
Hospital Israelita Albert EinsteinPhase 4

See all nortriptyline hydrochloride clinical trials

Pharmacology for nortriptyline hydrochloride
Medical Subject Heading (MeSH) Categories for nortriptyline hydrochloride

US Patents and Regulatory Information for nortriptyline hydrochloride

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Ani Pharms NORTRIPTYLINE HYDROCHLORIDE nortriptyline hydrochloride CAPSULE;ORAL 074054-004 Dec 31, 1992 DISCN No No See Plans and Pricing See Plans and Pricing See Plans and Pricing
Taro NORTRIPTYLINE HYDROCHLORIDE nortriptyline hydrochloride SOLUTION;ORAL 077965-001 Jun 20, 2006 AA RX No No See Plans and Pricing See Plans and Pricing See Plans and Pricing
Mylan NORTRIPTYLINE HYDROCHLORIDE nortriptyline hydrochloride CAPSULE;ORAL 074234-003 Jul 26, 1993 DISCN No No See Plans and Pricing See Plans and Pricing See Plans and Pricing
Specgx Llc PAMELOR nortriptyline hydrochloride SOLUTION;ORAL 018012-001 Approved Prior to Jan 1, 1982 DISCN No No See Plans and Pricing See Plans and Pricing See Plans and Pricing
Mayne Pharma NORTRIPTYLINE HYDROCHLORIDE nortriptyline hydrochloride CAPSULE;ORAL 073556-003 Mar 30, 1992 AB RX No No See Plans and Pricing See Plans and Pricing See Plans and Pricing
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for nortriptyline hydrochloride

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Lilly AVENTYL HYDROCHLORIDE nortriptyline hydrochloride CAPSULE;ORAL 014684-001 Approved Prior to Jan 1, 1982 See Plans and Pricing See Plans and Pricing
Specgx Llc PAMELOR nortriptyline hydrochloride SOLUTION;ORAL 018012-001 Approved Prior to Jan 1, 1982 See Plans and Pricing See Plans and Pricing
Ranbaxy AVENTYL nortriptyline hydrochloride SOLUTION;ORAL 014685-001 Approved Prior to Jan 1, 1982 See Plans and Pricing See Plans and Pricing
Specgx Llc PAMELOR nortriptyline hydrochloride CAPSULE;ORAL 018013-002 Approved Prior to Jan 1, 1982 See Plans and Pricing See Plans and Pricing
Specgx Llc PAMELOR nortriptyline hydrochloride CAPSULE;ORAL 018013-001 Approved Prior to Jan 1, 1982 See Plans and Pricing See Plans and Pricing
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Johnson and Johnson
Express Scripts
McKinsey
Boehringer Ingelheim
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.